Depression Drugs Market
Depression Drugs - Global Market Outlook (2019 -2027)
According to Stratistics MRC, the Global Depression Drugs Market is accounted for $12.38 billion in 2019 and is expected to reach $16.68 billion by 2027 growing at a CAGR of 3.8% during the forecast period. Some of the factors such as growing healthcare expenditure and increasing insurance coverage are anticipated to fuel the market growth. However, side effects associated with these drugs along with the availability of other treatment methods such as psychotherapy is hindering the market growth.
Depression drugs are medications used to treat major depressive disorders, some anxiety disorders, chronic pain conditions, and to help manage some addictions. Common side effects of depression drugs include dry mouth, weight gain, dizziness, headaches, and sexual dysfunction.
Based on the drug class, the serotonin and norepinephrine reuptake inhibitors (SNRIs) segment is likely to have a huge demand due to SNRIs help relieve depression symptoms, essentially sadness and irritability. These neurotransmitters are known to affect mood. Serotonin is also called a “feel-good” because it is accompanied by positive feelings of wellbeing. Norepinephrine is associated with alertness and energy. SNRIs help treat depression by maintaining the levels of these two neurotransmitters in the brain. They do this by discontinuing norepinephrine and serotonin from going back into the cells that released them.
By geography, North America is estimated to have a lucrative growth owing to high patient awareness levels regarding the availability of various drugs for depression, rising healthcare expenditure and the relatively larger number of R&D exercises on drug manufacturing and marketing, etc. these factors contribute for significant revenue generation from the region.
Some of the key players profiled in the Depression Drugs Market include Abbott, Allergan, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Pfizer, AstraZeneca, Bristol-Myers Squibb, Zhejiang NHU Company Ltd, and Sebela Pharmaceuticals.
Disease Types Covered:
• Generalized Anxiety Disorder
• Major Depressive Disorder
• Obsessive-Compulsive Disorders (OCD)
• Schizophrenia and Bipolar I Disorder
• Panic Disorder
• Other Disease Types
Drug Classes Covered:
• Atypical Antidepressants
• Selective Serotonin Reuptake Inhibitors (SSRIs)
• Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
• Tricyclic Antidepressants (TCAs)
• Anticonvulsants
• Beta-Blockers
• Norepinephrine-dopamine Reuptake Inhibitor (NDRI)
• Benzodiazepines
• Tetracyclic Antidepressants
• Monoamine Oxidase Inhibitors
• Central Nervous System (CNS) Stimulants
Distribution Channels Covered:
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies
Drug Types Covered:
• Branded Drugs
• Generic Drugs
Brands Covered:
• Zoloft
• Cymbalta
• Prozac
• Paxil
• Lexapro
• Prestiq
• Celexa
Applications Covered:
• Hospitals
• Prosthetic Clinics
• Rehabilitation Center
• Research Centres
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019 2020, 2024, and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Depression Drugs Market, By Disease Type
5.1 Introduction
5.2 Generalized Anxiety Disorder
5.3 Major Depressive Disorder
5.4 Obsessive-Compulsive Disorders (OCD)
5.5 Schizophrenia and Bipolar I Disorder
5.6 Panic Disorder
5.7 Other Disease Types
5.7.1 Elective Serotonin Reuptake Inhibitors (SSRIs)-Induced Disorder
5.7.2 Attention Deficit Hyperactivity Disorder (ADHD)
6 Global Depression Drugs Market, By Drug Class
6.1 Introduction
6.2 Atypical Antidepressants
6.3 Selective Serotonin Reuptake Inhibitors (SSRIs)
6.4 Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
6.5 Tricyclic Antidepressants (TCAs)
6.6 Anticonvulsants
6.7 Beta-Blockers
6.8 Norepinephrine-dopamine Reuptake Inhibitor (NDRI)
6.9 Benzodiazepines
6.10 Tetracyclic Antidepressants
6.11 Monoamine Oxidase Inhibitors
6.12 Central Nervous System (CNS) Stimulants
7 Global Depression Drugs Market, By Distribution Channel
7.1 Introduction
7.2 Hospital Pharmacies
7.3 Online Pharmacies
7.4 Retail Pharmacies
8 Global Depression Drugs Market, By Drug Type
8.1 Introduction
8.2 Branded Drugs
8.3 Generic Drugs
9 Global Depression Drugs Market, By Brand
9.1 Introduction
9.2 Zoloft
9.3 Cymbalta
9.4 Prozac
9.5 Paxil
9.6 Lexapro
9.7 Prestiq
9.8 Celexa
10 Global Depression Drugs Market, By Application
10.1 Introduction
10.2 Hospitals
10.3 Prosthetic Clinics
10.4 Rehabilitation Center
10.5 Research Centres
11 Global Depression Drugs Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Abbott
13.2 Allergan
13.3 Eli Lilly and Company
13.4 GlaxoSmithKline
13.5 Johnson & Johnson
13.6 Novartis AG
13.7 Otsuka Pharmaceutical Co., Ltd.,
13.8 Takeda Pharmaceutical Company Limited
13.9 Pfizer
13.10 AstraZeneca
13.11 Bristol-Myers Squibb
13.12 Zhejiang NHU Company Ltd
13.13 Sebela Pharmaceuticals
List of Tables
1 Global Depression Drugs Market Outlook, By Region (2018-2027) ($MN)
2 Global Depression Drugs Market Outlook, By Disease Type (2018-2027) ($MN)
3 Global Depression Drugs Market Outlook, By Generalized Anxiety Disorder (2018-2027) ($MN)
4 Global Depression Drugs Market Outlook, By Major Depressive Disorder (2018-2027) ($MN)
5 Global Depression Drugs Market Outlook, By Obsessive-Compulsive Disorders (OCD) (2018-2027) ($MN)
6 Global Depression Drugs Market Outlook, By Schizophrenia and Bipolar I Disorder (2018-2027) ($MN)
7 Global Depression Drugs Market Outlook, By Panic Disorder (2018-2027) ($MN)
8 Global Depression Drugs Market Outlook, By Other Disease Types (2018-2027) ($MN)
9 Global Depression Drugs Market Outlook, By Elective Serotonin Reuptake Inhibitors (SSRIs)-Induced Disorder (2018-2027) ($MN)
10 Global Depression Drugs Market Outlook, By Attention Deficit Hyperactivity Disorder (ADHD) (2018-2027) ($MN)
11 Global Depression Drugs Market Outlook, By Drug Class (2018-2027) ($MN)
12 Global Depression Drugs Market Outlook, By Atypical Antidepressants (2018-2027) ($MN)
13 Global Depression Drugs Market Outlook, By Selective Serotonin Reuptake Inhibitors (SSRIs) (2018-2027) ($MN)
14 Global Depression Drugs Market Outlook, By Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) (2018-2027) ($MN)
15 Global Depression Drugs Market Outlook, By Tricyclic Antidepressants (TCAs) (2018-2027) ($MN)
16 Global Depression Drugs Market Outlook, By Anticonvulsants (2018-2027) ($MN)
17 Global Depression Drugs Market Outlook, By Beta-Blockers (2018-2027) ($MN)
18 Global Depression Drugs Market Outlook, By Norepinephrine-dopamine Reuptake Inhibitor (NDRI) (2018-2027) ($MN)
19 Global Depression Drugs Market Outlook, By Benzodiazepines (2018-2027) ($MN)
20 Global Depression Drugs Market Outlook, By Tetracyclic Antidepressants (2018-2027) ($MN)
21 Global Depression Drugs Market Outlook, By Monoamine Oxidase Inhibitors (2018-2027) ($MN)
22 Global Depression Drugs Market Outlook, By Central Nervous System (CNS) Stimulants (2018-2027) ($MN)
23 Global Depression Drugs Market Outlook, By Distribution Channel (2018-2027) ($MN)
24 Global Depression Drugs Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
25 Global Depression Drugs Market Outlook, By Online Pharmacies (2018-2027) ($MN)
26 Global Depression Drugs Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
27 Global Depression Drugs Market Outlook, By Drug Type (2018-2027) ($MN)
28 Global Depression Drugs Market Outlook, By Branded Drugs (2018-2027) ($MN)
29 Global Depression Drugs Market Outlook, By Generic Drugs (2018-2027) ($MN)
30 Global Depression Drugs Market Outlook, By Zoloft (2018-2027) ($MN)
31 Global Depression Drugs Market Outlook, By Cymbalta (2018-2027) ($MN)
32 Global Depression Drugs Market Outlook, By Prozac (2018-2027) ($MN)
33 Global Depression Drugs Market Outlook, By Paxil (2018-2027) ($MN)
34 Global Depression Drugs Market Outlook, By Lexapro (2018-2027) ($MN)
35 Global Depression Drugs Market Outlook, By Prestiq (2018-2027) ($MN)
36 Global Depression Drugs Market Outlook, By Celexa (2018-2027) ($MN)
37 Global Depression Drugs Market Outlook, By Application (2018-2027) ($MN)
38 Global Depression Drugs Market Outlook, By Hospitals (2018-2027) ($MN)
39 Global Depression Drugs Market Outlook, By Prosthetic Clinics (2018-2027) ($MN)
40 Global Depression Drugs Market Outlook, By Rehabilitation Center (2018-2027) ($MN)
41 Global Depression Drugs Market Outlook, By Research Centres (2018-2027) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.